In the latter report, myoAAVs were used to deliver SaCas9 nuclease and sgRNAs in an mdx mouse model for DMD, to excise exon 23 and re-frame the Dmd transcript. This evidence concerns the gene DMD and Duchenne muscular dystrophy.